Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report.
COVID-19
Electrical storm
QTc prolongation
case report
hydroxychloroquine
ventricular tachycardia
Journal
SAGE open medical case reports
ISSN: 2050-313X
Titre abrégé: SAGE Open Med Case Rep
Pays: England
ID NLM: 101638686
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
09
2020
accepted:
27
10
2020
entrez:
26
11
2020
pubmed:
27
11
2020
medline:
27
11
2020
Statut:
epublish
Résumé
Hydroxychloroquine (HCQ) is a widely used drug to treat patients with coronavirus disease 19 (COVID-19). Although evidence of its efficacy and safety remains limited and controversial, both cardiac and non-cardiac adverse events are known to be associated with its use. To our knowledge, electrical storm in patients with COVID-19, or in any case treated with HCQ, has not been reported. We report the case of a 78-year-old male with an implantable cardiac resynchronization defibrillator (CRT-D) and a non-severe form of COVID-19. After a few days of home therapy with HCQ, an electrical storm was revealed that was associated with an increase in QTc. Following admission to the intensive care unit, HCQ was discontinued and progressive reduction of the QTc with electrical stabilization was observed. This clinical case highlights the potential risk of arrythmia associated with the use of HCQ and stresses the need for close electrocardiographic monitoring, especially in patients with established heart disease.
Identifiants
pubmed: 33240503
doi: 10.1177/2050313X20974217
pii: 10.1177_2050313X20974217
pmc: PMC7675879
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2050313X20974217Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
JAMA Netw Open. 2020 Apr 24;3(4):e208857
pubmed: 32330277
JAMA Cardiol. 2020 Sep 1;5(9):986-987
pubmed: 32936259
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
J Crit Care. 2020 Jun;57:279-283
pubmed: 32173110
JAMA Cardiol. 2020 Sep 1;5(9):1036-1041
pubmed: 32936252
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Circulation. 2018 Sep 25;138(13):e210-e271
pubmed: 29084733
Circulation. 2020 Jun 16;141(24):e906-e907
pubmed: 32267732
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Curr Opin Cardiol. 2013 Jan;28(1):72-9
pubmed: 23160339